NUKKLEUS INC (NUKK) Fundamental Analysis & Valuation

NASDAQ:NUKK • US67054R2031

Current stock price

2.06 USD
+0.16 (+8.42%)
At close:
2.07 USD
+0.01 (+0.49%)
After Hours:

This NUKK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. NUKK Profitability Analysis

1.1 Basic Checks

  • NUKK had negative earnings in the past year.
  • In the past year NUKK has reported a negative cash flow from operations.
  • NUKK had negative earnings in each of the past 5 years.
  • In the past 5 years NUKK always reported negative operating cash flow.
NUKK Yearly Net Income VS EBIT VS OCF VS FCFNUKK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2M -4M -6M -8M

1.2 Ratios

  • NUKK has a worse Return On Assets (-119.19%) than 94.58% of its industry peers.
Industry RankSector Rank
ROA -119.19%
ROE N/A
ROIC N/A
ROA(3y)-293.97%
ROA(5y)-177.05%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NUKK Yearly ROA, ROE, ROICNUKK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for NUKK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NUKK Yearly Profit, Operating, Gross MarginsNUKK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1 -1 -2 -3

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. NUKK Health Analysis

2.1 Basic Checks

  • NUKK has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for NUKK has been reduced compared to 5 years ago.
  • Compared to 1 year ago, NUKK has an improved debt to assets ratio.
NUKK Yearly Shares OutstandingNUKK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
NUKK Yearly Total Debt VS Total AssetsNUKK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

  • NUKK has an Altman-Z score of -30.36. This is a bad value and indicates that NUKK is not financially healthy and even has some risk of bankruptcy.
  • NUKK has a worse Altman-Z score (-30.36) than 94.58% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -30.36
ROIC/WACCN/A
WACCN/A
NUKK Yearly LT Debt VS Equity VS FCFNUKK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M -150M

2.3 Liquidity

  • A Current Ratio of 0.12 indicates that NUKK may have some problems paying its short term obligations.
  • The Current ratio of NUKK (0.12) is worse than 97.11% of its industry peers.
  • NUKK has a Quick Ratio of 0.12. This is a bad value and indicates that NUKK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NUKK has a worse Quick ratio (0.12) than 97.11% of its industry peers.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.12
NUKK Yearly Current Assets VS Current LiabilitesNUKK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. NUKK Growth Analysis

3.1 Past

  • The earnings per share for NUKK have decreased strongly by -3199.80% in the last year.
EPS 1Y (TTM)-3199.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-192.27%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NUKK Yearly Revenue VS EstimatesNUKK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 5M 10M 15M 20M

More info and screens

Find the best growth stocksShow best growing peers

0

4. NUKK Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NUKK. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NUKK Price Earnings VS Forward Price EarningsNUKK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NUKK Per share dataNUKK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -1 -2 -3 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NUKK Dividend Analysis

5.1 Amount

  • No dividends for NUKK!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NUKK Fundamentals: All Metrics, Ratios and Statistics

NUKKLEUS INC

NASDAQ:NUKK (2/6/2026, 8:00:01 PM)

After market: 2.07 +0.01 (+0.49%)

2.06

+0.16 (+8.42%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-03
Earnings (Next)05-01
Inst Owners4.32%
Inst Owner Change101.27%
Ins Owners11.93%
Ins Owner Change1.46%
Market Cap34.30M
Revenue(TTM)N/A
Net Income(TTM)-8.52M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.92
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS0
BVpS-3.21
TBVpS-3.21
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -119.19%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-293.97%
ROA(5y)-177.05%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 30916.3%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.12
Altman-Z -30.36
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3199.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-192.27%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-458.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-414.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-321.05%
OCF growth 3YN/A
OCF growth 5YN/A

NUKKLEUS INC / NUKK Fundamental Analysis FAQ

What is the fundamental rating for NUKK stock?

ChartMill assigns a fundamental rating of 0 / 10 to NUKK.


What is the valuation status of NUKKLEUS INC (NUKK) stock?

ChartMill assigns a valuation rating of 0 / 10 to NUKKLEUS INC (NUKK). This can be considered as Overvalued.


What is the profitability of NUKK stock?

NUKKLEUS INC (NUKK) has a profitability rating of 0 / 10.


What is the financial health of NUKKLEUS INC (NUKK) stock?

The financial health rating of NUKKLEUS INC (NUKK) is 1 / 10.